Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-05

Clinical Trial Update: Study of Bacteria on Mood and Bowel Symptoms in Patients With Irritable Bowel Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated a bacteria-based therapy for mood and bowel symptoms in patients with irritable bowel syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bacteria-based therapy for IBS

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Irritable Bowel Syndrome, IBS | Phase 1, Phase 2 | Status: COMPLETED